Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “DC”

306 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 306 results

Testing effectiveness (Phase 2)Temporarily pausedNCT02026362
What this trial is testing

Multiple Antigen Specific Cell Therapy (MASCT) for Hepatocellular Carcinoma(HCC) Patients After Radical Resection or Radio Frequency Ablation(RFA).

Who this might be right for
Hepatocellular Carcinoma
HRYZ Biotech Co. 100
Not applicableStudy completedNCT01472627
What this trial is testing

Effects of Bortezomib-Based Therapy on Cellular Immunity and Response to DC/Myeloma Fusion Vaccines in Vitro

Who this might be right for
Multiple Myeloma
Dana-Farber Cancer Institute 11
Not applicableUnknownNCT03496272
What this trial is testing

Atrial Fibrillation Cycle Length Measured on Transesophageal Echocardiography

Who this might be right for
Atrial Fibrillation
Pusan National University Yangsan Hospital 100
Not applicableLooking for participantsNCT06751953
What this trial is testing

Neoantigen-loaded DC Vaccine and Conventional Third-line Therapy for CRC Progressed After Second-line Treatment

Who this might be right for
Colorectal Cancer (CRC)
The First Affiliated Hospital of Nanchang University 10
Not applicableStudy completedNCT02450422
What this trial is testing

The Detection of Circulating Tumor Cells (CTCs) in Patients With Colorectal Cancer Undergoing Cryosurgery Combined With DC-CIK Treatment

Who this might be right for
Neoplastic Cells, Circulating
Fuda Cancer Hospital, Guangzhou 60
Testing effectiveness (Phase 2)Ended earlyNCT04276896
What this trial is testing

Immunity and Safety of Covid-19 Synthetic Minigene Vaccine

Who this might be right for
Pathogen Infection Covid-19 Infection
Shenzhen Geno-Immune Medical Institute 100
Early research (Phase 1)Study completedNCT02298946
What this trial is testing

AMP-224, a PD-1 Inhibitor, With Stereotactic Body Radiation Therapy in Metastatic Colorectal Cancer

Who this might be right for
Colorectal CancerColorectal NeoplasmsColorectal Carcinoma
National Cancer Institute (NCI) 17
Not applicableStudy completedNCT01691625
What this trial is testing

Concurrent Chemoradiation With or Without DC-CIK Immunotherapy in Treating Locally Advanced Esophageal Cancer

Who this might be right for
Esophageal Carcinoma
Capital Medical University 50
Early research (Phase 1)Study completedNCT02063724
What this trial is testing

HER-2 Pulsed DC Vaccine to Prevent Recurrence of Invasive Breast Cancer

Who this might be right for
Breast Cancer
H. Lee Moffitt Cancer Center and Research Institute 15
Not applicableUnknownNCT03158480
What this trial is testing

Safety and Efficacy of Immune Therapy for Condyloma

Who this might be right for
Condylomata Acuminata
Shenzhen Second People's Hospital 80
Not applicableUnknownNCT04559789
What this trial is testing

Reducing Dementia Risk With Digital Health Coaching

Who this might be right for
Alzheimer DiseaseDementiaMild Cognitive Impairment+1 more
Neurotrack Technologies, Inc. 200
Testing effectiveness (Phase 2)UnknownNCT04888611
What this trial is testing

Neoadjuvant PD-1 Antibody Alone or Combined With DC Vaccines for Recurrent Glioblastoma

Who this might be right for
Recurrent Glioblastoma
Huashan Hospital 40
Not applicableStudy completedNCT01906632
What this trial is testing

Gene Expression Profiling of Malignant Tumor Predict the Therapeutic Response of DC-CIK Immunotherapy

Who this might be right for
Malignant Tumor
Capital Medical University 50
Early research (Phase 1)Study completedNCT01525017
What this trial is testing

A Clinical Study to Evaluate Safety and Immunologic Response of COMBIG-DC, in Patients With Metastatic Kidney Cancer

Who this might be right for
Metastatic Renal Cell Carcinoma
Mendus 12
Not applicableStudy completedNCT00493597
What this trial is testing

Blood Endothelium Progenitor Cells and Dendritic Cells as Predictive Biomarkers of In-stent Restenosis

Who this might be right for
AtherosclerosisRestenosis
University Hospital, Antwerp 124
Early research (Phase 1)Looking for participantsNCT06799026
What this trial is testing

Vaccination With Dendritic Cell (DC)/Multiple Myeloma (MM) Fusions in Combination With Elranatamab in Relapsed or Refractory Multiple Myeloma

Who this might be right for
Multiple MyelomaRelapse Multiple MyelomaRefractory Multiple Myeloma
David Avigan 25
Early research (Phase 1)Study completedNCT02049489
What this trial is testing

ICT-121 Dendritic Cell Vaccine in Recurrent Glioblastoma

Who this might be right for
Glioblastoma Multiforme
Precision Life Sciences Group 20
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06790667
What this trial is testing

Comparison of Low-Level Laser Therapy and Transcutaneous Electrical Nerve Stimulation for Myofascial Pain in Temporomandibular Disorders

Who this might be right for
Myofascial Temporomandibular Disorders
University of Health Sciences Lahore 40
Not applicableStudy completedNCT06774196
What this trial is testing

Integrating Behavioral Therapy in the Management of Temporomandibular Disorders: A Comprehensive Evaluation Using DC/TMD Axis II Criteria

Who this might be right for
Temporomandibular Joint DisordersChronic PainAnxiety Disorders
King Khalid University 120
Large-scale testing (Phase 3)Study completedNCT00322452
What this trial is testing

First Line IRESSA™ Versus Carboplatin/Paclitaxel in Asia

Who this might be right for
Non-Small Cell Lung Cancer
AstraZeneca 1,329
Next Page